BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Drug Development

  Regeneron And Sanofi Announce Positive Phase 2 Study Results for Dupilumab in Patients With Active Moderate-to-Severe Eosinophilic Esophagitis

  Regeneron and Sanofi today announced positive results from a Phase 2 investigational study of dupilumab in adults with active moderate-to-severe eosinophilic esophagitis.

  October 16, 2017

   · 

  16 min read
• Drug Development

  Ardelyx Announces Tenapanor Reduces Pain Caused By IBS-C Through Inhibition Of TRPV-1 Signaling

  Ardelyx today reported that data from preclinical studies have shown that tenapanor works to reduce abdominal pain caused by irritable bowel syndrome with constipation (IBS-C) through the inhibition of TRPV-1 dependent signaling

  October 16, 2017

   · 

  6 min read
• Biotech Beach

  Ambry Presents Scientific Discovery to Enhance Clinical Practice at American Society for Human Genetics Annual Meeting (ASHG)

  Ambry Genetics Corporation (Ambry), a leading genetic testing lab, will be participating at the American Society of Human Genetics Annual Meeting (ASHG).

  October 16, 2017

   · 

  3 min read
• Policy

  ImmunoGen Announces Investigational New Drug Application for IMGN632 for Hematological Malignancies is Active

  ImmunoGen, Inc. today announced that the U.S. Food and Drug Administration (FDA) has completed the safety review of its investigational new drug (IND) application for IMGN632 in patients with CD123-positive hematological malignancies.

  October 16, 2017

   · 

  4 min read
• Lone Star Bio

  Protom International To Install Three-Room Proton Therapy System In China

  ProTom International Holding Company announces that it has signed a contract for the purchase and installation of a proton therapy system at the Boao Evergrande International Hospital in China’s Hainan Province.

  October 16, 2017

   · 

  2 min read
• BioMidwest

  Patients Battling Complex Regional Pain Syndrome Find A Host Of New Benefits In Abbott’s Proclaim DRG System

  Abbott today announced the U.S. launch of the company’s Proclaim DRG Neurostimulator System, a new device designed to deliver stimulation to the DRG and alleviate pain in patients suffering from CRPS of the lower limbs.

  October 16, 2017

   · 

  4 min read
• Biotech Beach

  Illumina Releases NovaSeq S4 Flow Cell and NovaSeq Xp Workflow

  Illumina, Inc. today announced the availability of the NovaSeq S4 flow cell, reagent kit and NovaSeq Xp workflow for its NovaSeq 6000 System.

  October 16, 2017

   · 

  4 min read
• 

  Business

  SafeHeal Names Former GI Dynamics Exec as CEO

  SafeHeal announced the appointment of Karl Blohm, Ph.D. as its new leader.

  October 16, 2017

   · 

  2 min read
• Biotech Beach

  Noninvasive PROMETHEUS FIBROSpect NASH Test Measures Severity of Liver Fibrosis

  Prometheus Laboratories introduces the FIBROSpect NASH test, a new tool to help healthcare providers stratify NASH patients by risk, based on the severity of their liver fibrosis.

  October 16, 2017

   · 

  3 min read
• Drug Development

  Aptevo Therapeutics Showcases New Mechanism of Action for Its ADAPTIR Platform at the Inflammation Research Society Meeting

  New Autoimmune Candidate APVO210 Demonstrates Targeted Cytokine Delivery for Application in Various Autoimmune and Inflammatory Diseases.

  October 16, 2017

   · 

  9 min read